Effect of continuous subcutaneous Treprostinil therapy on the pharmacodynamics and pharmacokinetics of warfarinWADE, Michael; HUNT, Thomas L; LAI, Allen A et al.Journal of cardiovascular pharmacology. 2003, Vol 41, Num 6, pp 908-915, issn 0160-2446, 8 p.Article

Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertensionWILLERS, Elisabeth D; NEWMAN, John H; HUMBERT, Marc et al.American journal of respiratory and critical care medicine. 2006, Vol 173, Num 7, pp 798-802, issn 1073-449X, 5 p.Article

Safety and efficacy of IV treprostinil for pulmonary arterial hypertension : A prospective, multicenter, open-label, 12-week trialTAPSON, Victor F; GOMBERG-MAITLAND, Mardi; MCLAUGHLIN, Vallerie V et al.Chest. 2006, Vol 129, Num 3, pp 683-688, issn 0012-3692, 6 p.Article

Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in childrenHISLOP, A. A; MOLEDINA, S; FOSTER, H et al.The European respiratory journal. 2011, Vol 38, Num 1, pp 70-77, issn 0903-1936, 8 p.Article

Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinilBARST, R. J; GALIE, N; NAEIJE, R et al.The European respiratory journal. 2006, Vol 28, Num 6, pp 1195-1203, issn 0903-1936, 9 p.Article

Elevated platelet angiostatin and circulating endothelial microfragments in idiopathic pulmonary arterial hypertension: A preliminary studyJURASZ, Paul; NG, Douglas; GRANTON, John T et al.Thrombosis research. 2010, Vol 125, Num 1, pp 53-60, issn 0049-3848, 8 p.Article

Impact of pulmonary vascular stiffness and vasodilator treatment in pediatric pulmonary hypertension: 21 patient-specific fluid―structure interaction studiesZHENBI SU; HUNTER, Kendall S; SHANDAS, Robin et al.Computer methods and programs in biomedicine (Print). 2012, Vol 108, Num 2, pp 617-628, issn 0169-2607, 12 p.Article

Pulmonary arterial hypertension associated with fenfluramine exposure : report of 109 cases. CommentaryWEIR, E. K; OBREZTCHIKOVA, M; HERVE, P et al.The European respiratory journal. 2008, Vol 31, Num 2, issn 0903-1936, 232-235, 343-348 [10 p.]Article

Medical therapy for pulmonary arterial hypertension: ACCP Evidence-based clinical practice guidelinesBADESCH, David B; ABMAN, Steve H; AHEARN, Gregory S et al.Chest. 2004, Vol 126, Num 1, pp S35-S62, issn 0012-3692, SUPArticle

EFFECTS OF VERAPAMIL AND ASPIRIN ON EXPERIMENTAL CHRONIC HYPOXIC PULMONARY HYPERTENSION AND RIGHT VENTRICULAR HYPERTROPHY IN RATSKENTERA D; SUSIC D; ZDRAVKOVIC M et al.1979; RESPIRATION; CHE; DA. 1979; VOL. 37; NO 4; PP. 192-196; BIBL. 9 REF.Article

Cytotoxic Cells and Granulysin in Pulmonary Arterial Hypertension and Pulmonary Veno-occlusive DiseasePERROS, Frédéric; COHEN-KAMINSKY, Sylvia; HUMBERT, Marc et al.American journal of respiratory and critical care medicine. 2013, Vol 187, Num 2, pp 189-196, issn 1073-449X, 8 p.Article

Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension: A Randomized, Controlled TrialJING, Zhi-Cheng; PARIKH, Keyur; ARNESON, Carl et al.Circulation (New York, N.Y.). 2013, Vol 127, Num 5, pp 624-633, issn 0009-7322, 10 p.Article

Lower Socioeconomic Status Is Associated with Worse Outcomes in Pulmonary Arterial HypertensionWU, Wen-Hui; LU YANG; KAWUT, Steven M et al.American journal of respiratory and critical care medicine. 2013, Vol 187, Num 3, pp 303-310, issn 1073-449X, 8 p.Article

Pulmonary arterial hypertension: a comparison between children and adultsBARST, R. J; ERTEL, S. I; BEGHETTI, M et al.The European respiratory journal. 2011, Vol 37, Num 3, pp 665-677, issn 0903-1936, 13 p.Article

Transgenic expression of human matrix metalloproteinase-9 augments monocrotaline-induced pulmonary arterial hypertension in miceGEORGE, Joseph; D'ARMIENTO, Jeanine.Journal of hypertension. 2011, Vol 29, Num 2, pp 299-308, issn 0263-6352, 10 p.Article

Dysregulation of the IL-13 Receptor System: A Novel Pathomechanism in Pulmonary Arterial HypertensionHECKER, Matthias; ZASLONA, Zbigniew; LOHMEYER, Jürgen et al.American journal of respiratory and critical care medicine. 2010, Vol 182, Num 6, pp 805-818, issn 1073-449X, 14 p.Article

The Cancer Paradigm of Severe Pulmonary Arterial HypertensionRAI, Pradeep R; COOL, Carlyne D; KING, Judy A. C et al.American journal of respiratory and critical care medicine. 2008, Vol 178, Num 6, pp 558-564, issn 1073-449X, 7 p.Article

Pulmonary arterial hypertension and its association with HIV infection : an overviewLEDERMAN, Michael M; SERENI, Daniel; SIMONNEAU, Gérald et al.AIDS (London). 2008, Vol 22, issn 0269-9370, S1-S6, SUP3Article

Identification of plasma protein biomarkers associated with idiopathic pulmonary arterial hypertensionABDUL-SALAM, Vahitha B; PAUL, Gideon A; OMARALI, J et al.Proteomics (Weinheim. Print). 2006, Vol 6, Num 7, pp 2286-2294, issn 1615-9853, 9 p.Article

Pulmonary arterial hypertensionRAIESDANA, Azad; LOSCALZO, Joseph.Annals of medicine (Helsinki). 2006, Vol 38, Num 2, pp 95-110, issn 0785-3890, 16 p.Article

Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertensionELLIOTT, C. Gregory; GLISSMEYER, Eric W; SCHMIDT, Jon W et al.Circulation (New York, N.Y.). 2006, Vol 113, Num 21, pp 2509-2515, issn 0009-7322, 7 p.Article

Role for DNA Damage Signaling in Pulmonary Arterial HypertensionMELOCHE, Jolyane; PFLIEGER, Aude; COUTURE, Christian et al.Circulation (New York, N.Y.). 2014, Vol 129, Num 7, pp 786-797, issn 0009-7322, 12 p.Article

Intralipid Prevents and Rescues Fatal Pulmonary Arterial Hypertension and Right Ventricular Failure in RatsUMAR, Soban; NADADUR, Rangarajan D; JINGYUAN LI et al.Hypertension (Dallas, Tex. 1979). 2011, Vol 58, Num 3, pp 512-518, issn 0194-911X, 7 p.Article

ACCF/AHA 2009 Expert Consensus Document on Pulmonary HypertensionCirculation (New York, N.Y.). 2009, Vol 119, Num 16, pp 2250-2294, issn 0009-7322, 45 p.Article

Fenfluramine-like cardiovascular side-effects of benfluorexBOUTET, K; FRACHON, I; JOBIC, Y et al.The European respiratory journal. 2009, Vol 33, Num 3, pp 684-688, issn 0903-1936, 5 p.Article